Search

everythinglearnresearchcommunity

for

Search:↓

HDAC6 helps keep ovarian follicles dormant, extending female fertility.

Human skin can produce steroids from cholesterol.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

Training improves consistency in evaluating polycystic ovaries with ultrasound.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

Different types of PCOS need specific diagnosis methods and treatments.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

The guidelines suggest reconsidering PCOS criteria for better diagnosis and care.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Understanding how acne develops in different diseases could lead to new treatments.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.